![Enterome completes €46.3 million ($52.6 million) financing to progress the clinical development of its therapeutic pipeline](https://www.seventure.fr/wp-content/uploads/2019/02/4__104270789-322x211.jpg)
25 June 2020
Enterome completes €46.3 million ($52.6 million) financing to progress the clinical development of its therapeutic pipeline
ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the microbiome-immunoinflammation axis to develop next-generation therapeutics, today...